+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

New halogenated estrogens with high binding affinity and selectivity for the estrogen receptor potential breast tumor imaging agents



New halogenated estrogens with high binding affinity and selectivity for the estrogen receptor potential breast tumor imaging agents



Journal of Nuclear Medicine 22(6): P20




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028789745

Download citation: RISBibTeXText


Related references

Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens. Journal of Medicinal Chemistry 23(9): 994-1002, 1980

Estrogen receptor-based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens. Journal of Medicinal Chemistry 23(9): 994-1002, 1980

Additions and Corrections - Estrogen Receptor Based Imaging Agents. 1. Synthesis and Receptor Binding Affinity of Some Aromatic and D-Ring Halogenated Estrogens. Journal of Medicinal Chemistry 24(12): 1540-1540, 1981

Molecular probes for the estrogen receptor affinity labels fluorescent estrogens and breast tumor imaging agents. Lambert, R W (Ed ) Royal Society Of Chemistry Special Publication, No 55 Third Sci-Rsc (Society Of Chemical Industry-Royal Society Of Chemistry) Medicinal Chemistry Symposium; Cambridge, England, Sept 15-18, 1985 Xii+384p The Royal Society Of Chemistry: London, England Illus Paper 312-321, 1986

Receptor-binding radiopharmaceuticals for imaging breast tumors: estrogen-receptor interactions and selectivity of tissue uptake of halogenated estrogen analogs. Journal of Nuclear Medicine 21(6): 550-558, 1980

Estrogen receptor based imaging agents. 2. Synthesis and receptor binding affinity of side-chain halogenated hexestrol derivatives. Journal of Medicinal Chemistry 23(9): 1002-1008, 1980

Halogenated estrogen analogs as potential breast tumor imaging agents. Cancer Treatment Reports 63(7): 1214, 1979

16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors. Journal of Medicinal Chemistry 36(11): 1619-1629, 1993

16.beta.-([18F]Fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors. Journal of Medicinal Chemistry 36(11): 1619-1629, 1993

Oxohexestrol derivatives labeled with fluorine-18. Synthesis, receptor binding and in vitro distribution of two non-steroidal estrogens as potential breast tumor imaging agents. Nuclear Medicine and Biology 21(1): 25-39, 1994

Fluorine-substituted cyclofenil derivatives as estrogen receptor ligands: synthesis and structure-affinity relationship study of potential positron emission tomography agents for imaging estrogen receptors in breast cancer. Journal of Medicinal Chemistry 49(8): 2496-2511, 2006

Novel 7α-alkoxy-17α-(4'-halophenylethynyl)estradiols as potential SPECT/PET imaging agents for estrogen receptor expressing tumours: synthesis and binding affinity evaluation. Steroids 77(11): 1123-1132, 2012

Estrogen linked cyto toxic agents of potential value for the treatment of breast cancer binding affinity for estrogen receptors. Genazzani, E , F Di Carlo And W I Mainwaring (Ed ) Pharmacological Modulation Of Steroid Action Xiv+297p Raven Press: New York, N Y , Usa Illus P217-226, 1980

Progestin-rhenium complexes: metal-labeled steroids with high receptor binding affinity, potential receptor-directed agents for diagnostic imaging or therapy. Bioconjugate Chemistry 2(5): 353-366, 1991

Synthesis and receptor binding properties of fluoro- and iodo-substituted high affinity sigma receptor ligands: identification of potential PET and SPECT sigma receptor imaging agents. Journal of Medicinal Chemistry 35(12): 2221-2230, 1992